目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Patient-based approach
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ASSUMPTIONS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ANTI-SNORING DEVICES MARKET OVERVIEW
4.2 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of sleep disorders
5.2.1.2 Increasing geriatric population and subsequent rise in obesity
5.2.1.3 Growing cigarette & alcohol consumption
5.2.1.4 Rising technological advancements in anti-snoring devices
5.2.2 RESTRAINTS
5.2.2.1 High price of customized oral appliances
5.2.2.2 Unreliable efficacy and inadequate studies for utilization
of anti-snoring devices
5.2.2.3 Social stigma associated with snoring
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding undiagnosed population
5.2.3.2 High growth potential of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Complex referral pathways and long waiting periods
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
5.3.2 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021-2023
5.3.3 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES
(ORAL APPLIANCES), BY REGION, 2021-2023 (USD)
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6.1 ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY LANDSCAPE
5.8.1.1 North America
5.8.1.1.1 US
5.8.1.1.1.1 Reimbursement scenario in US
5.8.1.1.2 Canada
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.3.1 Japan
5.8.1.3.2 China
5.8.1.3.3 India
5.8.1.3.4 Australia
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Asia Pacific
5.8.2.4 Latin America
5.8.2.5 Middle East & Africa
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Mandibular advancement devices
5.9.2 ADJACENT TECHNOLOGIES
5.9.2.1 Daytime-nighttime appliances
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY,
2019-2023 (USD MILLION)
5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY,
2019-2023 (USD MILLION)
5.11 PATENT ANALYSIS
5.12 KEY CONFERENCES & EVENTS, 2024−2025
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 BUYING CRITERIA
5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET
5.16 INVESTMENT & FUNDING SCENARIO
5.17 CASE STUDY ANALYSIS

6 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE
6.1 INTRODUCTION
6.2 ORAL APPLIANCES
6.2.1 MANDIBULAR ADVANCEMENT DEVICES
6.2.1.1 Ready-made mandibular advancement devices
6.2.1.1.1 Low cost to fuel uptake
6.2.1.2 Custom-made mandibular advancement devices
6.2.1.2.1 High efficacy to drive market
6.3 TONGUE-RETAINING/STABILIZING DEVICES
6.3.1 LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET
6.4 NASAL DEVICES
6.4.1 EXTERNAL NASAL DILATORS
6.4.1.1 Convenient and non-invasive benefits to boost demand
6.4.2 OTHER NASAL DEVICES
6.5 POSITION CONTROL DEVICES
6.6 CHIN STRAPS
6.7 EPAP THERAPY DEVICES

7 ANTI-SNORING DEVICES MARKET, BY GENDER
7.1 INTRODUCTION
7.2 MALE PATIENTS
7.2.1 HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS
TO PROPEL MARKET
7.3 FEMALE PATIENTS
7.3.1 RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET

8 ANTI-SNORING DEVICES MARKET, BY AGE GROUP
8.1 INTRODUCTION
8.2 BELOW 40 YEARS
8.2.1 LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS
TO RESTRAIN MARKET
8.3 BETWEEN 40-60 YEARS
8.3.1 INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET
8.4 ABOVE 60 YEARS
8.4.1 CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH

9 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
9.1 INTRODUCTION
9.2 ONLINE PHARMACIES
9.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
9.3 RETAIL PHARMACIES
9.3.1 CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET
9.4 HOSPITAL PHARMACIES
9.4.1 GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE

10 ANTI-SNORING DEVICES MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOME CARE SETTINGS
10.2.1 GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET
10.3 HOSPITALS & CLINICS
10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET

11 ANTI-SNORING DEVICES MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Rising trend of remote sleep testing to fuel uptake
11.2.3 CANADA
11.2.3.1 Increasing number of research grants for sleep apnea devices to boost demand
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 High prevalence of smoking to boost demand
11.3.3 UK
11.3.3.1 Rising awareness and increasing number of sleep service groups to support market growth
11.3.4 FRANCE
11.3.4.1 Rising geriatric population to fuel uptake
11.3.5 ITALY
11.3.5.1 Favorable initiatives for treatment of OSA to support market growth
11.3.6 SPAIN
11.3.6.1 Increasing initiatives for social awareness by regional organizations for treatment to drive market
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market
11.4.3 JAPAN
11.4.3.1 Rising demand for cloud-connected OSA therapy devices to boost demand
11.4.4 AUSTRALIA
11.4.4.1 Rising R&D initiatives for innovative sleep therapy devices to boost demand
11.4.5 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Favorable reimbursement policies for advanced sleep apnea procedures to drive market
11.5.3 MEXICO
11.5.3.1 Poor healthcare infrastructure to limit market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.7 GCC COUNTRIES
11.7.1 HIGH OBESITY RATES TO SUPPORT MARKET GROWTH
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Device footprint
12.5.5.4 Distribution channel footprint
12.5.5.5 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 RESMED
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Deals
13.1.1.3.2 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 SOMNOMED
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 MnM view
13.1.2.3.1 Key strengths
13.1.2.3.2 Strategic choices
13.1.2.3.3 Weaknesses & competitive threats
13.1.3 PROSOMNUS SLEEP TECHNOLOGIES
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Deals
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 VIVOS THERAPEUTICS, INC.
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product approvals
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.3.4 Other developments
13.1.5 DYNAFLEX
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.6 OPENAIRWAY
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Deals
13.1.7 PANTHERA DENTAL
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches
13.1.7.3.2 Deals
13.1.7.3.3 Other developments
13.1.8 AIRWAY MANAGEMENT
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches
13.1.9 APNEA SCIENCES
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 ORAVANOSA
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 MYERSON LLC
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 BRAEBON MEDICAL CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.2 OTHER PLAYERS
13.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
13.2.2 THE SNORE RELIEVER COMPANY, LLC
13.2.3 TOMED GMBH
13.2.4 THE AURUM GROUP
13.2.5 OSCIMED SA
13.2.6 SICAT GMBH & CO. KG
13.2.7 GLIDEWELL
13.2.8 APNOMED, INC.
13.2.9 ZQUIET
13.2.10 DREAM SYSTEMS DENTAL SLEEP LAB
13.2.11 PURE SLEEP COMPANY
13.2.12 THERAVENT, INC.
13.2.13 INNOVATIVE HEALTH TECHNOLOGIES

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS